Safety Announcement Concerning TNF Blockers

FDA Approved Biological Therapies

Safety Announcement Concerning TNF Blockers, The is informing the public that it continues to receive reports of a of (known as Hepatosplenic T-Cell or ), primarily in adolescents and young adults being treated for Crohn’s disease and with medicines known as (TNF) blockers, as well as with , and/or mercaptopurine.

Read the Safety Announcement Concerning TNF Blockers full storyFDA Safety Announcement Concerning TNF Blockers

Leave a Reply